InsiderClue
Insiders · Profile

Scherle Peggy

Chief Scientific Officer at Prelude Therapeutics. Filing since 7 Apr 2021. CIK 0001824632

Company
Date
Role
Action
Shares
Amount
Of holding
PRLD Prelude Therapeutics Inc
27 Aug 2021
Chief Scientific Officer
Sold, plan not stated
6,014
$215.97K
3.4%
PRLD Prelude Therapeutics Inc
26 Aug 2021
Chief Scientific Officer
Sold, plan not stated
1,700
$59.82K
1.0%
PRLD Prelude Therapeutics Inc
13 Aug 2021
Chief Scientific Officer
Sold, plan not stated
2,286
$80.16K
1.3%
PRLD Prelude Therapeutics Inc
27 Jul 2021
Chief Scientific Officer
Sold, plan not stated
20,000
$709.38K
10.4%
PRLD Prelude Therapeutics Inc
7 May 2021
Chief Scientific Officer
Sold, plan not stated
10,000
$408.19K
5.5%
PRLD Prelude Therapeutics Inc
8 Apr 2021
Chief Scientific Officer
Sold, plan not stated
4,630
$177.50K
2.6%
PRLD Prelude Therapeutics Inc
7 Apr 2021
Chief Scientific Officer
Sold, plan not stated
15,370
$604.14K
8.2%
7 decisions on file.